About

DrugPipelineForecast™ is a tool developed specifically for managed care professionals to address their unique needs.

This is a site which can help you track late-phase pipeline:

  • Products in late phase III to approval stages
  • All types of information for an in-depth review
  • Tabulated format for a quick analysis
  • Search and filtering capabilities
  • Default and customized reports
  • Frequent updates

Review pipeline developments on your terms

DrugPipelineForecast™ has been developed by InformaCeutica LLC, an independent organization which is not sponsored by any outside entity, to create a free pipeline database exclusively for use by managed care professionals. We integrate a variety of publicly available information, including company press releases, industry analyses, clinical trial developments, and emerging technology assessments, in order to compile a robust comprehensive database, which is updated on a bi-weekly basis. Click here for a demo to see the information collected for our full product profiles:

To be able to use DrugPipelineForecast™, visitors must be registered with DrugManagementForum, which is open to individuals who are currently employed by a health plan, PBM, specialty pharmacy, IPA, employer/benefits consultant, or another organization that is responsible for managing healthcare coverage. Individuals from academia or those with managed care experience who are currently consultants or freelancers can also join. Please note that User information that is collected for purposes of membership will not be sold or rented for marketing.

  • Click here to go to the forum registration or to view the terms of use that apply to both sites.

Those from other industry sectors who are interested in accessing DrugPipelineForecast™ data can subscribe for a fee of $249 per 6 months. Please contact us for more details (select "DrugPipelineForecast Issues" in the Subject section).

To begin the search, DrugPipelineForecast™ users must go to the Pipeline Forecast Search tab and log in with the User Name and Password issued by the DrugManagementForum™.